FFO
TECX

Fortitude Family Office’s Tectonic Therapeutic TECX Stock Holding History

Fortitude Family Office’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$464 Buy
+15
New +$369 ﹤0.01% 1758

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Fortitude Family Office's TECX Position: Q1 2026 in Review

Fortitude Family Office opened a new position in Tectonic Therapeutic (TECX) in Q1 2026: 15 shares worth $464. The stake represents ﹤0.01% of the portfolio and ranks #1758 among its holdings.

111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Fortitude Family Office held 15 shares of Tectonic Therapeutic worth $464 as of Q1 2026.
  • Tectonic Therapeutic was a new Fortitude Family Office position in Q1 2026.
  • Tectonic Therapeutic made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1758 holding.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.